Discontinued — last reported Q3 '23
Twilio Equity Method Investments decreased by 92.6% to $22.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $22.20M to $22.20M. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows an upward trend with a 100.5% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $66.30M | $68.30M | $69.30M | $74.30M | $74.30M | $699.91M | $30.70M | $30.70M | $30.70M | $593.58M | $31.10M | $31.10M | $30.30M | $485.84M | $22.20M | $22.20M | $20.30M | $301.64M | $22.20M |
| QoQ Change | — | +3.0% | +1.5% | +7.2% | +0.0% | +842.0% | -95.6% | +0.0% | +0.0% | >999% | -94.8% | +0.0% | -2.6% | >999% | -95.4% | +0.0% | -8.6% | >999% | -92.6% |
| YoY Change | — | — | — | — | +12.1% | +924.8% | -55.7% | -58.7% | -58.7% | -15.2% | +1.3% | +1.3% | -1.3% | -18.2% | -28.6% | -28.6% | -33.0% | -37.9% | +0.0% |